Adverum Biotechnologies, Inc. (NASDAQ: ADVM) went up by 26.05% from its latest closing price when compared to the 1-year high value of $7.72, while ADVM stocks collected +24.31% of gains with the last five trading sessions.

Adverum Biotechnologies, Inc. (NASDAQ: ADVM) Worth an Investment?

Adverum Biotechnologies, Inc. (NASDAQ: ADVM) The 36 Months beta value for ADVM stocks is at 3.19, while 2 of the analysts out of 5 who provided ratings for Adverum Biotechnologies, Inc. stocks as a “buy” while 0 as overweight, 3 rated it as hold and 0 as sell. The average price we get from analysts is $5.00 which is -$3.25 below current price. ADVM currently has a short float of 5.43% and public float of 46.37M with average trading volume of 479.84K shares.

ADVM Market Performance

ADVM stocks went up by 24.31% for the week, with the monthly jump of 36.87% and a quarterly performance of 132.29%, while its annual performance rate touched 35.50%. The simple moving average for the period of the last 20 days is 25.41% for ADVM stocks with the simple moving average of 70.90% for the last 200 days.

Analysts’ Opinion on Adverum Biotechnologies, Inc. (NASDAQ: ADVM)

Many brokerage firms have already submitted their reports for ADVM stocks, with SunTrust repeating the rating for ADVM shares by setting it to “Hold”. The predicted price for ADVM socks in the upcoming period according to SunTrust is $8 based on the research report published on November 2, 2018.

Raymond James, on the other hand, stated in their research note that they expect to see ADVM stock at the price of $8. The rating they have provided for ADVM stocks is “Mkt Perform” according to the report published on November 2, 2018.

Cantor Fitzgerald gave “Overweight” rating to ADVM stocks, setting the target price at $8 in the report published on September 21, 2018.

ADVM Stocks 40.12% Far from 50 Day Moving Average

After a stumble in the market that brought ADVM to its low price for the period of the last 52 weeks, Adverum Biotechnologies, Inc. was able to take a rebound, for now settling with 5.24% of profit for the given period.

The stock volatility was left at 7.31%, however, within the period of a single month, the volatility rate increased by 8.78%, while the shares surge at the distance of +43.89% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +82.70% upper at the present time.

In the course of the last 5 trading sessions, ADVM went up by +24.31%, which changed the moving average for the period of 200 days to the total of +72.98% of gains for the stock in comparison to the 20-day moving average settled at $6.61. In addition, Adverum Biotechnologies, Inc. saw 158.10% in overturn over the period of a single year with a tendency to cut further gains.

ADVM Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at Adverum Biotechnologies, Inc. (ADVM), starting from Scopa James Paul, who bought 20,000 shares at the price of $6.71 back on May 06. After this action, Rushing now owns 20,000 shares of Adverum Biotechnologies, Inc., valued at $134,200 with the latest closing price.

ADVM Stock Fundamentals

The current profitability levels are settled at -4533.56 for the present operating margin. The net margin for Adverum Biotechnologies, Inc. stands at -4505.40. Total capital return value is set at -37.94, while invested capital returns managed to touch -37.71. Equity return holds the value -33.40%, with -30.80% for asset returns.